Drug repurposing in COVID-19: A review with past, present and future
Research article
[키워드] ACE2
Applying
approach
approaches
approved
cause
clinical conditions
clinical trials
conducted
coronavirus disease
coronavirus SARS-CoV-2
COVID-19
COVID-19 disease
COVID19
drug
Drug repurposing
effective
Effectiveness
ENCODE
Favipiravir
FDA
food
Genome
global public health
host cell surface
identify
in vitro
infection process
initiate
Interaction
molecular docking
problems
protease inhibitors
Protein
Protein structure‐based drug design
Remdesivir
reuse
ribavirin
Ritonavir
RNA virus
SARS CoV2
SARS-CoV2
shown
single-stranded positive-sense
spike
structural proteins
therapeutic agent
Tocilizumab
treat
[DOI] 10.1016/j.metop.2021.100121 [Article Type] Research article
[DOI] 10.1016/j.metop.2021.100121 [Article Type] Research article